期刊文献+

附子理中汤治疗腹泻型肠易激综合征的疗效观察 被引量:21

Clinical efficacy of diarrhea predominant irritable bowel syndrome treated with Fuzi Lizhong Decoction
下载PDF
导出
摘要 目的探究附子理中汤对腹泻型肠易激综合征的临床疗效及对血清中炎症因子的影响。方法选择2016年5月至2018年4月期间接收的120例腹泻型肠易激综合患者为研究对象,按随机数字表法将研究对象随机分为对照组和治疗组,每组60例。对照组给予匹维溴铵,治疗组给予附子理中汤。对比两组治疗后的总有效率,对比两组治疗前后的IBS生活质量评分、SF-36生活质量评分以及血清中C反应蛋白(C-reactive protein,CRP)、肿瘤坏死因子-α(Tumor Necrosis Factor-α,TNF-α)和白细胞介素-6(Interleukin-6,IL-6)水平。结果治疗组总有效率优于对照组(P <0. 05);两组患者治疗后的IBS生活质量评分和SF-36生活质量评分均优于治疗前,治疗组治疗后IBS生活质量评分和SF-36生活质量评分优于对照组(P <0. 05);两组治疗后血清中CRP、TNF-α和IL-6水平均低于治疗前,治疗后治疗组血清中CRP、TNF-α和IL-6水平均低于对照组(P <0. 05)。结论附子理中汤治疗腹泻型肠易激综合征的临床疗效显著,改善患者的炎症反应效果更理想。 Objective To study the clinical efficacy of diarrhea predominant irritable bowel syndrome treated with Fuzi Lizhong Decoction and its effect on serum inflammatory factors.Methods From May 2016 to April 2018,120 patients with diarrhea-predominant irritable bowel syndrome were randomly divided into control group and treatment group with 60 cases in each group.The control group was treated with P-bromide,and the treatment group was given with Fuzi Lizhong Decoction.The total effective rate of the two groups after treatment was compared.The IBS quality of life score,SF-36 quality of life score,and serum levels of C-reactive protein(CRP),tumor necrosis factor-alpha(TNF-alpha)and interleukin-6(IL-6)were compared between the two groups before and after treatment.Results The total effective rate of treatment group was significantly higher than that of the control group(P<0.05).The scores of IBS quality of life and SF-36 quality of life after treatment in both groups were significantly higher than those before treatment.The scores of IBS quality of life and SF-36 quality of life in the treatment group were significantly higher than those in the control group after treatment(P<0.05).The serum levels of CRP,TNF-a and IL-6 in both groups were significantly lower than those before treatment.The serum levels of CRP,TNF-a and IL-6 in the treatment group were significantly lower than those in the control group after treatment(P<0.05).Conclusions Fuzi Lizhong Decoction have significant clinical effects on diarrhea-predominant irritable bowel syndrome,and the effect of improving inflammation is better.
作者 张明霞 王泽民 杜囚鹏 黄迎春 闫学平 ZHANG Ming-xia;WANG Ze-min;DU Qiu-peng;HUANG Ying-chun;YAN Xue-ping(Department of General Medicine,Beijing First Hospital of Integrated Chinese and Western Medicine,Beijing 100018;Department of Oncology,Wang Jing Hospital of CACMS,Beijing 100102)
出处 《世界中西医结合杂志》 2019年第5期704-706,740,共4页 World Journal of Integrated Traditional and Western Medicine
关键词 腹泻型肠易激综合征 附子理中汤 临床疗效 C反应蛋白 肿瘤坏死因子-Α 白细胞介素-6 Diarrhea predominant irritable bowel syndrome Fuzi Lizhong Decoction Clinical efficacy CRP TNF-α IL-6
  • 相关文献

参考文献15

二级参考文献201

共引文献1296

同被引文献310

引证文献21

二级引证文献112

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部